Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma.

MLA

Li, Shuo, et al. “Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals Tumor Heterogeneity and a Signature Based on NK Cell Marker Genes for Predicting Prognosis in Hepatocellular Carcinoma.” Frontiers in Pharmacology, vol. 14, June 2023, p. 1200114. EBSCOhost, https://doi.org/10.3389/fphar.2023.1200114.

APA

Li, S., Du, H., Gan, D., Li, X., Zao, X., & Ye, Y. (2023). Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma. Frontiers in Pharmacology, 14, 1200114. https://doi.org/10.3389/fphar.2023.1200114

Chicago

Li, Shuo, Hongbo Du, Da’nan Gan, Xiaoke Li, Xiaobin Zao, and Yong’an Ye. 2023. “Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals Tumor Heterogeneity and a Signature Based on NK Cell Marker Genes for Predicting Prognosis in Hepatocellular Carcinoma.” Frontiers in Pharmacology 14 (June): 1200114. doi:10.3389/fphar.2023.1200114.